Saw Palmetto vs Pygeum for BPH: Evidence | Dose Track
[Supplements · Comparison]

Saw palmetto vs pygeum: which prostate herb has better evidence?

Cochrane reviews · Evidence quality · Safety

Short answer: Saw palmetto has the newer and stronger evidence, and it is negative: a 2023 Cochrane review found little to no benefit for urinary symptoms of BPH.1 Pygeum's 2002 Cochrane review found better symptoms than placebo, but in 18 small, short trials with varied doses.2 No trial has compared the two herbs.

How do saw palmetto and pygeum compare side by side?

From two Cochrane reviews and NIH NCCIH.
Saw palmettoPygeum
SourceBerries of Serenoa repens, a small palm3Bark extract of the African prune tree2
Latest Cochrane review2023: 27 studies, 4,656 men12002: 18 trials, 1,562 men2
Main findingLittle to no difference in symptoms vs placebo (high-certainty evidence)1About twice as likely to report better overall symptoms vs placebo2
Trial length3 to 17 months1Average 64 days2
Compared with BPH drugs?Not in the 2023 review (placebo only)1No trials vs alpha blockers or 5-alpha reductase inhibitors2
SafetyWell tolerated up to 3 years; does not appear to affect PSA3Side effects mild and similar to placebo2

Reviewed . Half-life figures are shown only where the value Dose Track uses agrees with the cited source.

Why do the two reviews point different ways?

Saw palmetto has been studied in larger, more recent trials, including two NIH-funded ones. The 2023 Cochrane review, using only low-risk-of-bias studies for its main results, found little to no difference in symptoms or quality of life at 3 to 6 months and at 12 to 17 months.1 NCCIH concludes it is probably not helpful for BPH symptoms.3

Pygeum was last reviewed by Cochrane in 2002. Night-time urination fell by 19%, leftover urine by 24% and peak flow rose by 23% compared with placebo, but the reviewers warned the trials were small, short, used varied doses and preparations, and rarely used standard symptom scores.2

The two reviews differ in age, size and trial quality, so their results are not directly comparable.

What else should men know?

NCCIH says saw palmetto has been used safely in studies for up to 3 years, with infrequent digestive upset, dizziness or headache, and does not appear to change PSA readings.3 In the pygeum trials, side effects were mild and similar to placebo.2

Urinary symptoms can have other causes, so see your clinician before treating them yourself. Neither is approved by FDA before sale.4 More detail: Saw palmetto vs finasteride: what do the trials show?, and the Saw Palmetto (Serenoa repens) and Pygeum (Pygeum africanum) guides.

Frequently asked questions

Is pygeum better than saw palmetto?+
No trial has compared them. Pygeum's positive review is older and based on small, short trials; saw palmetto's newer review found little to no benefit.21
Does saw palmetto work for an enlarged prostate?+
A 2023 Cochrane review of 27 studies found it alone gives little to no benefit for urinary symptoms.1
Does saw palmetto affect PSA?+
NCCIH says it does not appear to affect PSA readings, even in higher-than-usual amounts.3
Has pygeum been compared with BPH drugs?+
Not in the Cochrane review; it found no trials against alpha blockers or 5-alpha reductase inhibitors.2
Can I track these in Dose Track?+
Yes. Log each one with reminders and add symptom notes for your clinician.